These patients have given NxStage permission to share their experiences with more frequent home therapy using the NxStage System One. Please note that the experiences and results reported by these patients will not necessarily be experienced by another patient. All patients differ and their experiences and results will vary. Also, training and treatment requirements reported by these patients are determined by their clinic. Your experiences and clinic requirements may differ. Patients on NxStage typically are prescribed to perform treatments 5 to 6 days per week at 2.5 to 3 hours per treatment.

Despite the health benefits that more frequent home haemodialysis may provide to those with chronic kidney disease, this form of therapy is not for everyone. The reported benefits of home haemodialysis may not be experienced by all patients. The risks associated with haemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. The medical devices used in haemodialysis therapies may add additional risks including air entering the bloodstream and blood loss due to clotting or accidental disconnection of the blood tubing set. Certain risks are unique to the home. Treatments at home are done without the presence of medical personnel and on-site technical support. Patients and their partners must be trained on what to do and how to get medical or technical help if needed.

Learn more about the responsibilities and risks of more frequent home haemodialysis.


APM1605 Rev. B